| HOME >> BIOLOGY >> TECHNOLOGY |
------------ ------------
NET (LOSS) INCOME (29,289) 390,600
OTHER COMPREHENSIVE
INCOME:
Foreign currency
translation adjustment 319,364 394,168
------------ ------------
COMPREHENSIVE (LOSS)
INCOME $ 290,075 $ 784,768
============ ============
INCOME (LOSS) PER
SHARE OF COMMON STOCK
BASIC
CONTINUING
OPERATIONS $ (0.001) $ 0.013
DISCONTINUED
OPERATIONS -- (0.002)
------------ ------------
Total-Basic $ (0.001) $ 0.011
============ ============
DILUTED
CONTINUING
OPERATIONS $ (0.001) $ 0.013
DISCONTINUED
OPERATIONS -- (0.002)
------------ ------------
Total-diluted $ (0.001) $ 0.011
============ ============
WEIGHTED AVERAGED NUMBER
OF SHARES OUTSTANDING
- BASIC 36,402,125 33,662,770
============ ============
WEIGHTED AVERAGED NUMBER
OF SHARES OUTSTANDING
- DILUTED 36,819,625 34,592,770
============ ============
For more information, please contact:
HCI Emerging Growth
Alan Sheinwald, Partner
Tel: +1-914-669-02
'/>"/>
SOURCE China Biopharmaceuticals Holdings, Inc.![]() Copyright©2007 PR Newswire. |